Saleh A Alkarim (Saleh Alkarim)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Acute Lymphoblastic Leukemia

Cancer Stem Cells

Cognitive Impairment

Angiotensin Converting Enzyme

Top Venues

Current issues in molecular biology

This page only lists publications with an associated author ORCID identifier.

Publications

Fatemah S Basingab, Reem A Alzahrani, Aisha A Alrofaidi, Ahmed Saleh Barefah, Rawan M Hammad, Hadil M Alahdal, Jehan S Alrahimi, Kawther A Zaher, Ali H Algiraigri, Mai M El-Daly, Saleh A Alkarim, Alia M Aldahlawi
Herpesvirus Entry Mediator as an Immune Checkpoint Target and a Potential Prognostic Biomarker in Myeloid and Lymphoid Leukemia. Biomolecules 14 (5) (2024)
Fatemah S Basingab, Reem A Alzahrani, Aisha A Alrofaidi, Ahmed Saleh Barefah, Rawan M Hammad, Hadil M Alahdal, Jehan S Alrahimi, Kawther A Zaher, Ali H Algiraigri, Mai M El-Daly, Saleh A Alkarim, Alia M Aldahlawi
Herpesvirus Entry Mediator as an Immune Checkpoint Target and a Potential Prognostic Biomarker in Myeloid and Lymphoid Leukemia. Biomolecules 14 (5) (2024)
Wafaa S Ramadan, Saleh A Alkarim, Mohammed Moulay, Ghadeer I Alrefaei, Fatma M Al-Qudsi, Khalid Rehman Hakeem, Ashwaq Iskander
Modulation of the Tumor Microenvironment by Ellagic Acid in Rat Model for Hepatocellular Carcinoma: A Potential Target against Hepatic Cancer Stem Cells. Cancers 15 (19) (2023)
F A Dain Md Opo, Saleh A Alkarim, Ghadeer I Alrefaei, Mohammad Habibur Rahman Molla, Nouf H Alsubhi, Faisal Abdulrahman Alzahrani, Foysal Ahammad
Pharmacophore-Model-Based Virtual-Screening Approaches Identified Novel Natural Molecular Candidates for Treating Human Neuroblastoma. Current issues in molecular biology 44 (10) (2022)
Mohamed A Zayed, Samar Sultan, Hashem O Alsaab, Shimaa Mohammad Yousof, Ghadeer I Alrefaei, Nouf H Alsubhi, Saleh A Alkarim, Kholoud S Al Ghamdi, Sali Abubaker Bagabir, Ankit Jana, Badrah S Alghamdi, Hazem M Atta, Ghulam Md Ashraf
Stem-Cell-Based Therapy: The Celestial Weapon against Neurological Disorders. Cells 11 (21) (2022)